LENZ Therapeutics (LENZ) Stock Insights

LENZ price $3.21 +0.06 +1.90%

Ticker
LENZ
Price
$3.21
Change
+0.06 +1.90%
Market cap ?
$100.86M
Beta ?
1.73
Sector
Healthcare
Industry
Biotechnology

Fair value

LENZ fair value $10.28. Price $3.21. Price is 69% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.72M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.7). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 31.42M. Net debt -24.36M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare LENZ

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—-0.89—4.20M
2026-08-11-1.02-1.055.49M2.38M
2026-05-11-1.32-1.101.90M1.76M
2026-03-24-1.16-0.911.59M3.08M
2025-11-05-0.59-0.6712.50M3.09M
2025-07-30-0.53-0.585.00M714.29K
2025-05-07-0.53-0.55—714.29K
2025-03-19-0.46-0.42——
2024-11-06-0.38-0.46——
2024-08-14-0.40-0.49——
2024-05-08-3.53-0.84——
2024-02-27-0.40-0.13——
2023-11-13-2.75-1.75——
2023-08-14-6.79-6.79——
2023-05-11-3.01-2.41——
2023-03-20-3.08-3.45——
2022-11-09-3.15-3.11——
2022-08-11-3.36-3.44——
2022-05-12-3.36-2.73——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Weekly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2024-03-22$7.212024-03-18—Weekly
2024-03-15$7.21——Weekly

Insider trades

DateInsiderActionSharesPriceValue
2026-06-15RA CAPITAL MANAGEMENT, L.P.Buy22.10K$6.63146.52K
2026-06-15George Jeffrey P.Buy22.10K$6.63146.52K
2026-06-15Drapkin Kimberlee CBuy22.10K$6.63146.52K
2026-06-15MCCOLLUM JAMES WBuy22.10K$6.63146.52K
2026-06-15Thunen Shelley BBuy22.10K$6.63146.52K
2026-06-15Guerard FredericBuy22.10K$6.63146.52K
2026-06-15Scheiner ZacharyBuy22.10K$6.63146.52K
2026-03-27George Jeffrey P.Buy5.59K$8.9249.89K
2026-03-27Schimmelpennink Evert B.Buy28.09K$8.95251.41K
2026-03-27Chevallard Daniel R.Buy7.50K$8.5764.28K
2026-01-02Olsson ShawnBuy84.20K$16.001.35M
2026-01-02Olsson ShawnBuy14.00K——
2026-01-02Odrich MarcBuy84.20K$16.001.35M
2026-01-02Odrich MarcBuy14.00K——
2026-01-02Chevallard Daniel R.Buy84.20K$16.001.35M
2026-01-02Chevallard Daniel R.Buy14.00K——
2026-01-02Schimmelpennink Evert B.Buy358.10K$16.005.73M
2025-11-17Olsson ShawnSell10.00K$2.0820.80K
2025-11-17Olsson ShawnBuy10.00K$2.0820.80K
2025-11-17Olsson ShawnSell4.21K$25.74108.41K
2025-11-17Olsson ShawnSell5.79K$26.37152.61K
2025-11-07MCCOLLUM JAMES WBuy10.50K$22.79239.28K
2025-11-07Chevallard Daniel R.Buy2.18K$22.7649.56K
2025-11-07Chevallard Daniel R.Buy20$22.71454
2025-09-30Versant Venture Capital VI, L.P.Sell49.70K$45.352.25M
2025-09-30Versant Venture Capital VI, L.P.Sell83.07K$46.413.85M
2025-09-30Versant Venture Capital VI, L.P.Sell177$47.018.32K
2025-09-30Versant Venture Capital VI, L.P.Sell34.41K$45.351.56M
2025-09-30Versant Venture Capital VI, L.P.Sell57.50K$46.412.67M
2025-09-30Versant Venture Capital VI, L.P.Sell123$47.015.78K
2025-09-18Versant Venture Capital VI, L.P.Sell49.48K$41.592.06M
2025-09-18Versant Venture Capital VI, L.P.Sell40.91K$43.001.76M
2025-09-18Versant Venture Capital VI, L.P.Sell268$43.3011.60K
2025-09-18Versant Venture Capital VI, L.P.Sell24.37K$41.591.01M
2025-09-18Versant Venture Capital VI, L.P.Sell20.15K$43.00866.44K
2025-09-18Versant Venture Capital VI, L.P.Sell132$43.305.72K
2025-08-26Versant Venture Capital VI, L.P.Sell43.98K$38.971.71M
2025-08-26Versant Venture Capital VI, L.P.Sell3.46K$39.50136.88K
2025-08-26Versant Venture Capital VI, L.P.Sell21.66K$38.97844.22K
2025-08-26Versant Venture Capital VI, L.P.Sell1.71K$39.5067.43K
2025-08-25Versant Venture Capital VI, L.P.Sell50.27K$39.531.99M
2025-08-25Versant Venture Capital VI, L.P.Sell2.15K$39.9285.79K
2025-08-25Versant Venture Capital VI, L.P.Sell24.76K$39.53978.65K
2025-08-25Versant Venture Capital VI, L.P.Sell1.06K$39.9242.24K
2025-08-22Versant Venture Capital VI, L.P.Sell20.49K$40.03820.33K
2025-08-22Versant Venture Capital VI, L.P.Sell5.67K$40.59230.06K
2025-08-22Versant Venture Capital VI, L.P.Sell10.08K$40.03403.34K
2025-08-22Versant Venture Capital VI, L.P.Sell2.81K$40.59114.02K
2025-08-18Versant Venture Capital VI, L.P.Sell30.63K$38.561.18M
2025-08-18Versant Venture Capital VI, L.P.Sell15.09K$38.56581.69K
2025-08-15Versant Venture Capital VI, L.P.Sell145.05K$39.505.73M
2025-08-15Versant Venture Capital VI, L.P.Sell69.95K$39.502.76M
2025-07-10Versant Venture Capital VI, L.P.Sell191.38K$34.006.51M
2025-06-27Versant Venture Capital VI, L.P.Sell200.00K$30.466.09M
2025-06-20Versant Venture Capital VI, L.P.Sell133.92K$30.254.05M
2025-06-20Versant Venture Capital VI, L.P.Sell100.88K$30.353.06M
2025-06-18Versant Venture Capital VI, L.P.Sell100.00K$29.953.00M
2025-06-11RA CAPITAL MANAGEMENT, L.P.Buy13.50K$30.00405.00K
2025-06-11George Jeffrey P.Buy13.50K$30.00405.00K
2025-06-11Drapkin Kimberlee CBuy13.50K$30.00405.00K
2025-06-11Guerard FredericBuy13.50K$30.00405.00K
2025-06-11Thunen Shelley BBuy13.50K$30.00405.00K
2025-06-11MCCOLLUM JAMES WBuy13.50K$30.00405.00K
2025-06-11Scheiner ZacharyBuy13.50K$30.00405.00K
2025-06-10Versant Venture Capital VI, L.P.Sell350.00K$29.0010.15M
2025-04-09Olsson ShawnSell1.40K$2.082.91K
2025-04-09Olsson ShawnBuy1.40K$2.082.91K
2025-03-07Schimmelpennink Evert B.Sell4.20K$1.044.37K
2025-03-07Schimmelpennink Evert B.Buy4.20K$1.044.37K
2025-01-09Olsson ShawnBuy80.10K$26.342.11M
2025-01-09Odrich MarcBuy80.10K$26.342.11M
2025-01-09Chevallard Daniel R.Buy70.44K$26.341.86M
2025-01-09Schimmelpennink Evert B.Buy279.10K$26.347.35M
2024-12-16Olsson ShawnSell3.33K$2.086.93K
2024-12-16Olsson ShawnBuy3.33K$2.086.93K
2024-07-22Schimmelpennink Evert B.Sell45.00K$1.0446.80K
2024-07-22Schimmelpennink Evert B.Buy45.00K$1.0446.80K
2024-05-14Chevallard Daniel R.Buy3.19K$15.6849.99K
2024-05-13MCCOLLUM JAMES WBuy31.33K$15.99501.09K
2024-03-21Alpha Wave Ventures GP, LtdOther0——
2024-03-21Alpha Wave Ventures GP, LtdOther0——
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy933.04K$15.0314.02M
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy2.39M——
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy64.97K$15.03976.51K
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy694.75K——
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy164.73K——
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy54.58K$10.64580.75K
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy27.00K$15.05406.35K
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy10.58K$10.64112.57K
2024-03-21RA CAPITAL MANAGEMENT, L.P.Buy5.37K$10.6457.15K
2024-03-21RA CAPITAL MANAGEMENT, L.P.Other0——
2024-03-21Thunen Shelley BBuy27.00K$15.05406.35K
2024-03-21MCCOLLUM JAMES WBuy16.63K$15.03249.99K
2024-03-21MCCOLLUM JAMES WBuy477.60K——
2024-03-21MCCOLLUM JAMES WBuy95.03K——
2024-03-21MCCOLLUM JAMES WBuy27.00K$15.05406.35K
2024-03-21MCCOLLUM JAMES WBuy6.58K$10.6469.96K
2024-03-21Guerard FredericBuy30.90K$2.0864.27K
2024-03-21Guerard FredericBuy27.00K$15.05406.35K
2024-03-21Guerard FredericBuy23.57K$6.04142.37K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 152, holders 0 vs prior quarter. Ownership 111.21%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.4.18M00.00%23.74M
ALPHA WAVE GLOBAL, LP3.61M00.00%20.52M
FMR LLC3.56M-38.88K-1.08%20.21M
VERSANT VENTURE MANAGEMENT, LLC2.66M00.00%15.09M
BLACKROCK, INC.2.29M315.30K+15.95%13.02M
SQUAREPOINT OPS LLC1.75M240.60K+15.97%9.92M
ABERDEEN GROUP PLC1.55M391.72K+33.88%8.79M
MILLENNIUM MANAGEMENT LLC1.51M639.22K+73.54%8.57M
VANGUARD CAPITAL MANAGEMENT LLC1.10M56.57K+5.43%6.24M
72 INVESTMENT HOLDINGS, LLC1.02M00.00%5.78M
BLUE OWL CAPITAL HOLDINGS LP756.72K250.00K+49.34%4.30M
C WORLDWIDE GROUP HOLDING A/S700.00K00.00%3.98M
GEODE CAPITAL MANAGEMENT, LLC564.66K40.09K+7.64%3.21M
TREXQUANT INVESTMENT LP497.53K283.12K+132.05%2.83M
MARSHALL WACE, LLP493.10K332.83K+207.68%2.80M
QUBE RESEARCH & TECHNOLOGIES LTD482.19K482.19KNew2.74M
MORGAN STANLEY473.00K-175.85K-27.10%2.69M
PRIMECAP MANAGEMENT CO/CA/472.20K00.00%2.68M
TANG CAPITAL MANAGEMENT LLC451.11K00.00%2.56M
ALYESKA INVESTMENT GROUP, L.P.438.88K-24.61K-5.31%2.49M
STATE STREET CORP406.67K4.45K+1.11%2.31M
CITADEL ADVISORS LLC363.23K287.93K+382.38%2.06M
TWO SIGMA INVESTMENTS, LP285.58K-215.41K-43.00%1.62M
ROCK SPRINGS CAPITAL MANAGEMENT LP257.46K00.00%1.46M
BANK OF AMERICA CORP /DE/255.41K-292.12K-53.35%1.45M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

LENZ Therapeutics (LENZ) Stock Insights

LENZ$3.21+0.06 +1.90%

$100.86M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History